CX3CR1 and rheumatoid arthritis: This study offers promising insights and targets for the restoration of the CX3CR1+ macrophage barrier for RA treatment, highlighting energy metabolism as a key target and expanding the potential application of mitochondrial therapy in regenerative medicine.